cariprazine Articles
Forest Labs files NDA for cariprazine for schizophrenia and bipolar indications; patent settlements
29 November 2012
Forest Labs, Gedeon Richter plan 2012 filing for cariprazine
29 February 2012
More strong data on Forest and Richter antipsychotic cariprazine
9 February 2012
Showing 1-4 of 4 articles
- 1
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
